National Cancer Institute
Found 163 results for your search:
Total relevant funding to Gene Therapy for this search:
$37,266,434
Fiscal Year FY 2016
Research Topic [Gene Therapy]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 163 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers 1R33CA202900-01 $418,128 $418,128 BREUNIG, JOSHUA CEDARS-SINAI MEDICAL CENTER
2
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer 5R01CA175318-02 $354,563 $354,563 HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J.
3
A novel miR-198 replacement therapy for pancreatic cancer 5R01CA183984-02 $473,915 $236,958 YAO, QIZHI BAYLOR COLLEGE OF MEDICINE
4
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas 5R01CA198076-02 $618,770 $309,385 PORTNOW, JANA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
5
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer 4R01CA168900-05 $332,000 $332,000 POWELL, DANIEL UNIVERSITY OF PENNSYLVANIA
6
Adenoviral delivery of protein-based therapeutics to the tumor microenvironment 5F32CA189372-02 $45,444 $45,444 SMITH, SHEENA UNIVERSITY OF ZURICH
7
Adenoviral delivery of protein-based therapeutics to the tumor microenvironment 5F32CA189372-02X1 $8,850 $8,850 SMITH, SHEENA UNIVERSITY OF ZURICH
8
Adoptive Cell Transfer Immunotherapy of Cancer ZIA BC 010984 $1,726,433 $690,573 Rosenberg, Steven CCR (NCI)
9
Adoptive T cell Therapy for Pediatric Leukemia ZIA BC 011565 $1,035,891 $310,767 Fry, Terry CCR (NCI)
10
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $41,944 $41,944 Kochenderfer, James CCR (NCI)
11
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer 4K08CA163941-05 $173,772 $86,886 MOON, EDMUND UNIVERSITY OF PENNSYLVANIA
12
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011413 $167,778 $167,778 Kochenderfer, James CCR (NCI)
13
Biology and Transplantation of the Hematopoietic Stem Cell 5P01CA065493-22 $1,914,901 $421,278 WAGNER, JOHN UNIVERSITY OF MINNESOTA
14
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma 3R01CA183827-02S1 $137,964 $137,964 QUINONES-HINOJOSA, ALFREDO JOHNS HOPKINS UNIVERSITY
15
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma 5R01CA183827-02 $333,518 $333,518 QUINONES-HINOJOSA, ALFREDO JOHNS HOPKINS UNIVERSITY
16
Building on the success of the adoptive immunotherapy of cancer ZIA BC 010763 $1,579,134 $394,783 Restifo, Nicholas CCR (NCI)
17
Cancer Immunotherapy by Targeting A2 Adenosine Receptor 4R01CA111985-10 $214,407 $70,754 SITKOVSKY, MICHAIL NORTHEASTERN UNIVERSITY
18
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis 4R01CA166590-04 $319,550 $159,775 CAO, LEI OHIO STATE UNIVERSITY
19
Career Development in Pediatric and Medical Oncology 2K12CA076930-16A1 $531,466 $175,384 BERNSTEIN, IRWIN FRED HUTCHINSON CANCER RESEARCH CENTER
20
Cell Production Core Facility ZIC BC 011569 $803,455 $401,727 Somerville, Robert CCR (NCI)
21
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment 5R21CA193064-03 $288,035 $288,035 BHATNAGAR, PARIJAT SRI INTERNATIONAL
22
Chronic Lymphocytic Leukemia Research Consortium 4P01CA081534-16 $3,104,311 $620,862 KIPPS, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO
23
Clinical management of patients on immunotherapy protocols ZID BC 011578 $15,439 $4,632 Klebanoff, Christopher CCR (NCI)
24
Clinical production of viral vectors for cancer gene therapy ZIC BC 010989 $451,117 $451,117 Feldman, Steven CCR (NCI)
25
Combination Gene Therapy and Th1-Th2 Therapy ZIA BC 011219 $252,285 $126,143 Fowler, Daniel CCR (NCI)
26
Combination Therapy of OvCa with Oligonucleotides and Photodynamic Therapy 1R01CA194064-01A1 $84,166 $42,083 MING, XIN UNIV OF NORTH CAROLINA CHAPEL HILL
27
Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy 7R01CA194064-02 $193,994 $96,997 MING, XIN WAKE FOREST UNIVERSITY HEALTH SCIENCES
28
Combining STAT3-silencing and oncolytic vaccinia virus to enhance anti-tumor therapeutic activity 1F32CA199981-01A1 $56,118 $56,118 BYRD, DANIEL UNIVERSITY OF PITTSBURGH AT PITTSBURGH
29
Common hTERT Promoter Mutations Represent a Novel Therapeutic Target 1R21CA191663-01A1 $167,023 $167,023 MILLER, DONALD UNIVERSITY OF LOUISVILLE
30
CRLF2 signaling in B-cell acute lymphoblastic leukemia 2R01CA151898-06A1 $392,969 $196,485 WEINSTOCK, DAVID DANA-FARBER CANCER INST
31
CRLF2 signaling in B-cell acute lymphoblastic leukemia 3R01CA151898-06A1S1 $199,999 $100,000 WEINSTOCK, DAVID DANA-FARBER CANCER INST
32
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment 4R01CA177932-04 $309,175 $309,175 KIM, SUNG WAN UNIVERSITY OF UTAH
33
Developing a Novel System for Cancer Therapy: Tumor-Targeted Inhibition of Oncogenic MicroRNAs 5F30CA196020-02 $27,876 $13,938 SVORONOS, ALEXANDER YALE UNIVERSITY
34
Developing inducible CRISPR to identify molecular targets in melanoma 5R21CA192241-02 $162,038 $162,038 VANBROCKLIN, MATTHEW UNIVERSITY OF UTAH
35
Developing novel strategies for altering the cytokine microenvironment of tumors 5R21CA184433-02 $200,318 $200,318 FRELINGER, JOHN UNIVERSITY OF ROCHESTER
36
Development of fully-human anti-CD30 chimeric antigen receptors ZIA BC 011660 $125,833 $125,833 Kochenderfer, James CCR (NCI)
37
DF/HCC Kidney Cancer SPORE 5P50CA101942-12 $2,156,131 $258,736 MCDERMOTT, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER
38
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome 2R01CA143167-06A1 $425,390 $425,390 HILL, DANA CHILDREN'S RESEARCH INSTITUTE
39
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia 5R01CA196604-02 $354,563 $177,282 CHIANG, MARK UNIVERSITY OF MICHIGAN
40
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery 1R01CA196947-01A1 $361,974 $361,974 FIGUEIREDO, MARXA PURDUE UNIVERSITY
41
DNA-specific pattern recognition receptor activation following DNA electroporation 1R01CA196796-01A1 $329,919 $164,960 HELLER, LOREE OLD DOMINION UNIVERSITY
42
Duke SPORE in Brain Cancer 5P50CA190991-03 $2,036,564 $81,463 SAMPSON, JOHN DUKE UNIVERSITY
43
Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies 6R00CA181491-03 $250,586 $125,293 BALKO, JUSTIN VANDERBILT UNIVERSITY MEDICAL CENTER
44
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression 5R01CA186730-02 $367,893 $367,893 HELLER, RICHARD OLD DOMINION UNIVERSITY
45
Elucidating the role of microRNAs in the initiation of multiple myeloma 5R00CA172292-04 $248,999 $74,700 ZHAO, JIANJUN CLEVELAND CLINIC LERNER COM-CWRU
46
Enhancing Antitumor Immunity by Suppressing TGF-Beta Signaling in CD8+ T Cells 5F31CA196258-02 $33,695 $16,848 PUPLAMPU-DOVE, YVONNE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
47
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity 4R01CA114425-10 $303,371 $151,686 WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY
48
Enhancing Immunological Memory Using Aptamer targeted siRNA Delivery to T Cells 3R01CA181598-03S1 $100,813 $50,407 GILBOA, ELI UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
49
Enhancing Immunological Memory Using Aptamertargeted siRNA Delivery to T Cells 5R01CA181598-03 $318,513 $159,257 GILBOA, ELI UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
50
Enhancing T Cell Therapy of Cancer 4P01CA094237-14 $1,932,287 $966,144 HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE
Total relevant funding to Gene Therapy for this search: $37,266,434
Showing 1 - 50 of 163 results
Go to top